681 articles in this topic
Virtual reality combined with yoga breathing techniques successfully taught people with cervical spinal cord injuries to self-regulate blood pressure.
High-dose nicotinamide riboside increased atherosclerotic plaques and inflammation in mice, challenging NAD+ supplement safety.
New ACC findings reveal cardiovascular benefits of PCSK9 inhibitors in diabetes patients and tirzepatide's kidney protection effects.
New JAMA study shows lifestyle interventions can significantly reduce cardiovascular risk in hypertensive patients.
Landmark 10-year follow-up compares stenting versus bypass surgery for critical left main coronary artery blockages.
New review reveals how telomere shortening drives cardiovascular aging and identifies promising therapeutic targets for heart health.
Comprehensive analysis of cardiovascular disease trends across 204 countries reveals persistent global health challenges.
NEJM publishes erratum for Phase 2a study of baxdrostat in primary aldosteronism treatment
New research examines silent aspiration, a dangerous condition where patients inhale food or liquids without obvious symptoms.
New oral drug MK-0616 matches injectable PCSK9 inhibitors for lowering LDL cholesterol while offering patient-friendly pill form.
Large genetic analysis of 552 adults reveals oral health and cardiovascular disease may not share common genetic pathways as previously thought.
New research shows GDF11, an anti-aging protein, prevents dangerous calcium buildup in arteries by suppressing inflammatory pathways.
